Conceptio
›
Archive
›
NCBI PubMed Central
NCBI PubMed Central
open access
Ipilimumab and nivolumab for cancer treatment: a pharmacovigilance study based on the FDA adverse event reporting system database.
Liu R et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗
Direct PDF ↓
legal informatics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record
· ID 338507
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.